Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies

Oncogene
Stefan DuensingKarl Münger

Abstract

Dysregulation of the centrosome duplication cycle has been implicated in tumorigenesis. Our previous work has shown that the human papillomavirus type 16 (HPV-16) E7 oncoprotein rapidly induces aberrant centrosome and centriole duplication in normal human cells. We report here that HPV E7-induced abnormal centriole duplication is specifically abrogated by a small molecule CDK inhibitor, indirubin-3'-oxime (IO), but not a kinase-inactive derivative. Importantly, normal centriole duplication was not markedly affected by IO, and the inhibitory effects were observed at concentrations that did not affect the G1/S transition of the cell division cycle. Depletion of CDK2 by siRNA similarly abrogated HPV E7-induced abnormal centrosome duplication and ectopic expression of CDK2 in combination with cyclin E or cyclin A could rescue the inhibitory effect of IO. IO treatment also reduced the steady-state level of aneuploid cells in HPV-16 E7-expressing cell populations. Our results suggest that cyclin/CDK2 activity is critically involved in abnormal centrosome duplication induced by HPV-16 E7 oncoprotein expression, but may be dispensable for normal centrosome duplication and cell cycle progression.

References

Apr 21, 1990·British Dental Journal·J P Waterhouse, D K Mason
Jan 1, 1986·Cell Motility and the Cytoskeleton·R KuriyamaG G Borisy
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·A SchulzeB Henglein
Jan 1, 1994·Annual Review of Biochemistry·D R KelloggB M Alberts
Oct 9, 1996·Biochimica Et Biophysica Acta·H zur Hausen
Jan 1, 1999·Nature·C LengauerB Vogelstein
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·K R LaceyT Stearns
Jul 17, 1999·British Journal of Cancer·Y TokuchiE Tsuchiya
Sep 28, 1999·Nature·C H SpruckS I Reed
Feb 9, 2000·Current Biology : CB·A KhodjakovC L Rieder
Jan 17, 2002·Current Opinion in Cell Biology·Michel Bornens
Jun 28, 2002·Cancer Cell·Richard D Klausner
Oct 4, 2002·Developmental Cell·Zhihong ChenBrian David Dynlacht
Nov 5, 2002·Nature Reviews. Cancer·Erich A Nigg
Nov 26, 2002·Virus Research·Karl Münger, Peter M Howley
Apr 5, 2003·Cancer Cell·Osamu Tetsu, Frank McCormick
May 27, 2003·Nature Cell Biology·Connie Wong, Tim Stearns
Aug 19, 2003·Nature Genetics·Sagrario OrtegaMariano Barbacid

❮ Previous
Next ❯

Citations

May 22, 2008·Pathology Oncology Research : POR·Ioannis N MammasDemetrios A Spandidos
May 8, 2009·Oncogene·N GammohL Banks
Sep 7, 2007·Molecular Biology of the Cell·Christopher KasbekHarold A Fisk
Nov 2, 2011·International Journal of Biological Sciences·Jason Yongsheng Chan
Sep 20, 2011·Future Virology·Pavel A Nikitin, Micah A Luftig
Apr 10, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Andrea ArenzClaus Wittekindt
May 16, 2013·Organic & Biomolecular Chemistry·Friedrich ErbenPeter Langer
Dec 10, 2015·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Marco Raffaele Cosenza, Alwin Krämer
Jun 23, 2009·Virus Research·Margaret E McLaughlin-Drubin, Karl Münger
Apr 25, 2008·Bioorganic & Medicinal Chemistry·Stefanie LibnowPeter Langer
Jun 5, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D MastrangeloT Hadjistilianou
Mar 28, 2009·Environmental and Molecular Mutagenesis·Anette DuensingStefan Duensing
Jul 10, 2009·International Journal of Cancer. Journal International Du Cancer·Thomas F Schulz
Jul 28, 2007·International Journal of Cancer. Journal International Du Cancer·Domenico MastrangeloTheodora Hadjistilianou
Nov 19, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Muhammad ZahoorKang-Yell Choi
Apr 8, 2006·Medical Hypotheses·Ying Chen, Qingzhong Kong
Oct 13, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Tina BlaževićPavel Uhrin
Jan 15, 2014·Seminars in Cancer Biology·Nicholas A Wallace, Denise A Galloway
Oct 16, 2012·Expert Opinion on Therapeutic Targets·Nina KorzeniewskiStefan Duensing
Nov 15, 2008·Virology·Margaret E McLaughlin-Drubin, Karl Münger
Jan 26, 2007·Antiviral Chemistry & Chemotherapy·Luis M SchangJonathan J Lacasse
Aug 1, 2019·International Journal of Oncology·Yu LiuXiaorong Qi
Apr 19, 2006·Cancer Research·Eiji SugiharaMasanao Miwa
Jan 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Soo-A KimJung-Hoon Yoon
Nov 6, 2021·Cell Division·Yair Alfaro-MoraJosé Díaz-Chávez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.